Posted 16 September 2016 - 04:39 PM

This article explores some of the regulatory challenges facing those who would bring rejuvenation biotechnologies, like those pursued by Dr. Aubrey de Grey and the SENS Foundation, to market. It does not presume familiarity with Dr. de Grey and his work; I’ve tried to make it informative to all alike. The Conquest of Aging Biomedical […]Visit the Institute for Evidence-Based Cryonics for the complete post, other content, and more.